biologicpatentwatch.com
Subscribe to BiologicPatentWatch
http://www.biologicpatentwatch.com/subscribe.php
BiologicPatentWatch Plans and Pricing. Recurring charge, cancel anytime. 9658; Instant Access. One-time charge, three months free. 9658; Instant Access. Recurring charge, cancel anytime. 9658; Instant Access. One-time charge, three months free. 9658; Instant Access. Ensp; Data Export. 9658; Instant Access. Ensp; Data Export. Preview the database — try a trial. Supplementary Protection Certificates (SPCs). Drug Master File Listings. Emsp; Additional Users. Do you have any questions, or need a pro forma.
biotechblog.com
Cancer's Science Revolution Comes on Little Cat Feet – Biotechblog
http://www.biotechblog.com/2015/04/09/cancers-science-revolution-comes-on-little-cat-feet
Cancer's Science Revolution Comes on Little Cat Feet. April 9, 2015. Posted in: General Biotechnology. This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Back when I wrote ISO A Scientific Revolution in Cancer Research. And pharmaceutical R&D for oncology immunotherapy has been surging ever since. This is really good news for cancer patients and their families. Formerly known as Bacillus prodigiosus.
biotechblog.com
Giving Angel Investors Their Wings: R&D Investment Tax Credits – Biotechblog
http://www.biotechblog.com/2015/04/21/giving-angel-investors-wings-rd-investment-tax-credits
Giving Angel Investors Their Wings: R&D Investment Tax Credits. April 21, 2015. Posted in: General Biotechnology. This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Nascent life sciences start-ups in the BRICS and other emerging markets face continuing fundraising hurdles, as discussed here. And more recently here. Accordingly, the Modi Government should look beyond public sectors funding schemes for b...
biotechblog.com
Biotechblog – Page 2 – Biotechnology business, policy, and more!
http://www.biotechblog.com/page/2
Mainstreaming the Microbiome Part 2. June 28, 2016. Posted in: General Biotechnology. This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In mid-April I noted the quickening pace of commercial investment in microbiome translational research and made what now seems like a paltry prediction to the effect that: the […]. Drug Patent Expirations for Jun 23, 2016. June 23, 2016. June 22, 2016. June 16, 2016.
biotechblog.com
Biotechblog – Page 3 – Biotechnology business, policy, and more!
http://www.biotechblog.com/page/3
Biotech in Countries Starting with “I” Part 10: India. May 13, 2016. Posted in: General Biotechnology. This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Warning: This next entry in the series: Biotech in Countries Starting with I is a ‘feel-good’ update on India’s new National Intellectual Property Rights Policy, released May 12, […]. Drug Patent Expirations for May 12, 2016. May 12, 2016. May 5, 2016.
SOCIAL ENGAGEMENT